After NICE okay, Scots denied access to Vifor’s Veltassa

10 November 2020 - The SMC has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s ...

Read more →

New osteoporosis drug for women approved for use on NHS in Scotland

9 October 2020 - A new drug to treat women with severe cases of the bone disease osteoporosis has been ...

Read more →

SMC - November 2020 decisions

9 November 2020 - Advice on eight new medicines for use in conditions including breast cancer, lung cancer and osteoporosis has ...

Read more →

Scotland backs two myeloma drugs turned down by NICE in England

14 October 2020 - A north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines ...

Read more →

SMC accepts Bavencio (avelumab) in combination with axitinib for the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma

12 October 2020 - Merck and Pfizer announced today that the Scottish Medicines Consortium has accepted the immunotherapy Bavencio (avelumab) for ...

Read more →

SMC - October 2020 decisions

12 October 2020 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...

Read more →

Update on SMC remobilisation

2 October 2020 - SMC business recovery following the early stages of the COVID-19 pandemic continues to progress well. ...

Read more →

SMC plays key role in helping to secure access to COVID-19 treatments

15 September 2020 - The Scottish Medicines Consortium is part of a UK-wide multi-agency initiative to secure access to potential ...

Read more →

Scottish Medicines Consortium accepts nasal spray for depression previously rejected by NICE

8 September 2020 - Esketamine nasal spray can now be provided on the NHS in Scotland for adults with major depressive ...

Read more →

Alimera Sciences obtains reimbursement approval for Iluvien use in non-infectious posterior uveitis in Scotland

8 September 2020 - Alimera Sciences announces that the Scottish Medicines Consortium, after completing its assessment and review, has accepted (per ...

Read more →

SMC accepts three new health technologies for interim use

7 September 2020 - In what appears to be a new process, the SMC has accepted three new technologies for ...

Read more →

ICR welcomes approval of immunotherapy for head and neck cancer in Scotland but warns of ‘home nations lottery’

7 September 2020 - The Institute of Cancer Research, London, has welcomed the approval by the Scottish Medicines Consortium of ...

Read more →

Four new medicines accepted by SMC through an expedited approach

7 September 2020 - Medicines accepted to minimise delay in patient access following the early phase of the COVID-19 pandemic. ...

Read more →

SMC recommends Merck's Keytruda for another two indications

7 September 2020 - Pembrolizumab (Keytruda) has been accepted for the treatment of patients with head and neck squamous cell carcinoma ...

Read more →

SMC accepts Spravato (esketamine) nasal spray for use in adults with treatment-resistant major depressive disorder in Scotland

7 September 2020 - SMC acceptance comes less than a week after second rejection by NICE. ...

Read more →